Ocular complications of HIV/AIDS in the era of HAART.

Bittencourt, Millena G.; Agbedia, Owhofasa O.; Liu, Hong T.; Annam, Rachel; Sepah, Yasir J.; Leder, Henry Alexander; Sophie, Raafay; Ibrahim, Mohamed; Akhtar, Abeer; Akhlaq, Anam; Diana V. Do; Quan Dong Nguyen

Mortality associated with AIDS has declined after the introduction of highly active antiretroviral therapy (HAART) with fewer patients progressing to severe infections. This has affected the incidence and management of HIV complications to a great extent. The natural history, incidence, management and sequelae of a wide range of HIV-associated retinopathies, especially cytomegalovirus retinitis, have also drastically changed. The reduction in the incidence of ocular opportunistic infections due to HAART has been accompanied by a rise in the number of new HAART-associated syndromes such as immune recovery uveitis. Immune recovery uveitis is a HAART-dependent inflammatory response that may occur in patients with regressed cytomegalovirus retinitis and elevated CD4 count and has emerged as an important cause of ocular and visual morbidity.

EYE diseases; GANCICLOVIR; HIV infection complications; QUALITY of life; AIDS-related opportunistic infections; HIGHLY active antiretroviral therapy; IMMUNOCOMPROMISED patients; DISEASE risk factors; THERAPEUTICS

Expert Review of Ophthalmology, 2012, Vol 7, Issue 6, p555

1746-9899

Academic Journal

10.1586/EOP.12.65